Xvivo Perfusion: Q1 preview

Research Note

2020-04-08

12:22

Xvivo is scheduled to release its first-quarter earnings results tomorrow before the stock market opens. Following the release, the company will host a telephone conference at 11:30 a.m. CET. In line with guidance, we expect to see a significant impact from the coronavirus outbreak in Q1. However, we argue that Xvivo is well positioned in the medtech sector and believe that the effect will be short-term.

AN

Arvid Necander

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.